Investor Contact & FAQ’s

If you have questions or need help, please see our FAQ’s section or contact our Investor Relations team

Frequently Asked Questions

Perspective Therapeutics is listed on the NYSE MKT and trades under the ticker symbol “CATX”.

Perspective Therapeutics went public in 2005 and was formerly known as Isoray, Inc. which traded under the ticker symbol “ISR”.  Following a merger with Viewpoint Molecular Targeting, Inc. in February 2023 the Company changed its name to Perspective Therapeutics, Inc. and its ticker symbol to “CATX”.

T: 1-800-962-4284
462 S. 4th St., Louisville, KY 40202

Perspective Therapeutics’ CUSIP number is 46489V104.

Perspective Therapeutics, Inc. is incorporated in Deleware.

Perspective Therapeutics’ corporate headquarters are located at 350 Hills Street, Suite 106, Richland WA  99354.

Perspective Therapeutics does not currently pay dividends on its common stock.

Please contact Perspective Therapeutics’ transfer agent, Computershare.

Perspective Therapeutics’ fiscal year end is December 31.

Assure CPA, LLC
7307 N Division Street
Suite 222
Spokane, WA  99208

Investor Contact

    Scroll to top